Manufacturing Committee

The Mission:

To build relationships between biopharmaceutical manufacturing professionals through peer-to-peer collaboration via BioNJ membership, and to educate and inform the New Jersey life-sciences community on all aspects of the manufacturing of biopharmaceuticals to facilitate scientific and medical advancement. Additionally, to elevate awareness of manufacturing-related resources and expertise within the state of New Jersey.

The Vision:

A highly networked ecosystem where biopharmaceutical manufacturing professionals collectively leverage best practices and experience to optimize capabilities and opportunities for life science growth and success within New Jersey.

Committee Members

C0-Chair Pfizer, Robert Lechich, Director, Supply Chain Management
C0-Chair Ulteemit BioConsulting, Michael Ultee, Ph.D.
Aprecia, Jae Yoo, Chief Technology Officer
Hovione, Marco Marques, General Manager
Chemical & Pharmaceutical Solutions, James Bruno, Managing Director
McKinsey & Company, Andrea Gennari, Partner
McKinsey & Company, Alessandro Delfino, Partner
McKinsey & Company, Katie Kelleher, Associate Partner
NJII, Haro Hartounian, Executive Director, Biopharmaceutical Lab
Novartis Technical Operations/Sandoz, Ariel Alon, VP, Americas & Special Technologies
Patheon, Franco Negron, President, Commercial Operations, Pharma Services
PendoTech, Jim Furey, President & CEO
Pepper Hamilton, Tim Atkins, Partner
Reed Smith LLP, Betty Yan, Partner
Regional Personnel Services, James Lynch, President
Rutgers University, Doug Hausner, Ph.D., Associate Director for Industrial Relations & Business Development
Rutgers University, Fernando Muzzio, Dir., NSF ERC on Structured Organic Systems
Rutgers University, Vincent Smeraglia, Executive Director, Office of Research Commercialization
Thermo Fisher, Mark Maxwell, Senior Business Development Executive – Biologics